With the advent of atypical antipsychotics, quality of life for patients wi
th schizophrenia has improved significantly. The positive effects are based
not only on the compliance-enhancing reduction of extrapyramidal side effe
cts but also due to improved cognitive function and social integration, sho
rter duration,and overall reduction of hospital treatment.
Numerous controlled studies have addressed the issue of switching patients
from typical to atypical antipsychotics. However, published data on substit
uting one atypical antipsychotic for another a re preliminary and very limi
ted.
This case report describes acute side effects which occurred when switching
from clozapine to amisulpride and discusses mechanisms on the receptor lev
el. Regarding these two agents, the clinical relevance of the knowledge of
receptor profiles outlined.